Physician profile
Kimberly Bartley
NPI 1881126621
$3,575.29
in general payments reported to CMS, 2019-2025
34 companies · $843 in 2025
The $843 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $95.86 · 2021: $846 · 2022: $748 · 2023: $599 · 2024: $443 · 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,885.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $454.23 | 2021-2025 | |
| Novo Nordisk INC | $452.90 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $378.75 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $276.36 | 2020-2024 | Veozah |
| Astrazeneca Pharmaceuticals LP | $249.68 | 2020-2025 | Farxiga, Breztri |
| Glaxosmithkline, LLC. | $186.22 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Otsuka America Pharmaceutical, INC. | $174.89 | 2022-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $152.07 | 2021-2025 | Lagevrio, Steglatro, Belsomra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.96 | 2021-2025 | Jardiance, Ofev |
| Abbvie INC. | $127.55 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $116.44 | 2021-2022 | |
| Esperion Therapeutics, INC. | $106.47 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.93 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.68 | 2021-2025 | Xifaxan |
| Dynavax Technologies Corporation | $63.40 | 2021-2025 | Heplisav-B |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $59.35 | 2021-2022 | |
| Axsome Therapeutics, INC. | $54.64 | 2025 | Auvelity |
| Inspire Medical Systems, INC. | $40.84 | 2023-2025 | Inspire |
| Lundbeck LLC | $39.23 | 2025 | Rexulti |
| Nestle Healthcare Nutrition INC. | $38.73 | 2021 | |
| Amarin Pharma, INC. | $38.34 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $35.22 | 2022-2023 | Quviviq |
| Adlon Therapeutics L.P. | $33.48 | 2021 | |
| Amgen INC. | $29.43 | 2021-2025 | Otezla, Repatha |
| Hologic Sales and Service, LLC | $24.97 | 2021 | |
| Noven Therapeutics, LLC | $21.01 | 2024 | Xelstrym |
| Biohaven Pharmaceuticals, INC. | $20.48 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.90 | 2022 | |
| Phathom Pharmaceuticals, INC. | $17.44 | 2025 | Voquezna |
| Kyowa Kirin, INC. | $16.82 | 2025 | |
| Sanofi-Aventis U.S. LLC | $14.76 | 2022 | |
| Avanir Pharmaceuticals, INC. | $13.70 | 2020 | |
| Eisai INC. | $13.22 | 2020 | |
| Horizon Therapeutics Plc | $12.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Bartley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.